Currently, the exact mechanisms of the impact of COVID-19 on women's reproductive health remain poorly defined. Purpose of the study is to assess the hormonal function of patients with infertility and long-term COVID-19. Materials and methods. The main group consisted of 80 women with infertility who had symptoms of "long-COVID", the comparison group - 40 patients without a history of COVID-19. Hormonal studies of follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin, melatonin, estradiol (E2), progesterone (P), free testosterone (Tf), dehydroepiandrosterone (DHEA), cortisol, anti-Müllerian hormone (AMH) were conducted. Results. Violation of gonadotropic regulation of reproductive function is manifested by an increase in the serum concentration of LH and FSH and an increase in their ratio. A tendency to hyperprolactinemia, a relative decrease in serum melatonin was revealed. A more than 2-fold increase in the E2/P ratio on the 22nd day of the menstrual cycle indicates a tendency to hyperestrogenemia. An increase in the level of serum androgens (Tf and DHEA), which also play a role in female reproduction, was detected. Elevated levels of the stress hormone cortisol can negatively affect the chances of getting pregnant in assisted reproductive technologies programs. A decrease in AMH was observed in patients with infertility and long-term COVID-19, indicating a decrease in their ovarian reserve. Conclusion. The identified neuro-endocrine changes in patients with infertility and long-term COVID-19, due to the direct and indirect effects of the transmitted disease and its consequences, may be a marker of reduced reproductive potential and unsuccessful attempts to use assisted reproductive technologies.
Read full abstract